The Allstate Corporation (NYSE:ALL) Stock Has Consensus Price Target of $270.19 According to Brokerages

The Allstate Corporation (NYSE:ALL) has received a consensus rating of “Hold” from the twenty-two analysts that are covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a sell recommendation, nine have given a hold recommendation, eight have issued a buy recommendation and two have assigned a strong buy recommendation to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $270.19.

Several brokerages recently issued reports on ALL. Argus set a $238.00 target price on shares of Allstate in a research note on Friday, August 28th. Jefferies Financial Group reduced their price objective on shares of Allstate from $310.00 to $292.00 and set a “buy” rating for the company in a research report on Tuesday, October 6th. BMO Capital Markets lifted their target price on shares of Allstate from $250.00 to $284.00 and gave the stock an “outperform” rating in a report on Thursday, August 13th. TD Cowen increased their target price on Allstate from $231.00 to $260.00 and gave the stock a “hold” rating in a research note on Wednesday, September 23rd. Finally, The Goldman Sachs Group reduced their price target on Allstate from $280.00 to $250.00 and set a “neutral” rating for the company in a research note on Thursday, October 1st.

Insider Buying and Selling at Allstate

In other news, COO Mario Rizzo sold 56,225 shares of the company’s stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $264.48, for a total value of $14,870,388.00. Following the completion of the transaction, the chief operating officer owned 82,227 shares of the company’s stock, valued at $21,747,396.96. This represents a 40.61% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider John E. Dugenske sold 32,996 shares of the company’s stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $269.33, for a total transaction of $8,886,812.68. Following the completion of the transaction, the insider owned 13,054 shares of the company’s stock, valued at approximately $3,515,833.82. This trade represents a 71.65% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 1.55% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Allstate

Several institutional investors and hedge funds have recently made changes to their positions in the business. BlackRock Inc. bought a new stake in Allstate in the second quarter valued at $5,439,448,000. Bank of America Corp DE raised its holdings in Allstate by 8.1% during the first quarter. Bank of America Corp DE now owns 7,913,320 shares of the insurance provider’s stock worth $1,640,748,000 after buying an additional 596,321 shares during the last quarter. GQG Partners LLC bought a new position in shares of Allstate in the second quarter valued at $1,245,710,000. Deutsche Bank AG acquired a new stake in shares of Allstate in the 2nd quarter worth about $1,008,648,000. Finally, Dimensional Fund Advisors LP boosted its stake in Allstate by 5.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,804,615 shares of the insurance provider’s stock valued at $581,515,000 after purchasing an additional 154,259 shares during the last quarter. Institutional investors own 76.47% of the company’s stock.

More Allstate News

Here are the key news stories impacting Allstate this week:

• Positive Sentiment: Allstate prevailed in a Texas coverage dispute involving a vacant property. The ruling supports the insurer’s ability to enforce policy vacancy provisions, potentially limiting claims costs and reinforcing underwriting discipline. Vacant clause can void cover: US court backs Allstate in Texas case
• Positive Sentiment: Allstate retained $9,000 in a subrogation-related dispute after a court placed the premature filing cost on the opposing liability carrier. The financial impact is small, but the decision may support Allstate’s claims-handling position. Allstate keeps $9,000 as premature subrogation cost falls on liability carrier
• Positive Sentiment: Bank of America raised its price target on Allstate to $340 from $336, signaling continued confidence in the insurer’s earnings outlook and valuation. BofA raises target from $336 to $340
• Positive Sentiment: A valuation-focused analysis said Allstate still appears inexpensive despite a 131% advance, potentially attracting investors who expect further benefits from strong insurance pricing and improved profitability. Allstate stock still looks cheap after its 131% run
• Neutral Sentiment: Allstate shares gained 3.76% in the referenced session, although KBW maintained its Sell rating, highlighting a disconnect between short-term trading momentum and analyst conviction. KBW keeps Sell rating
• Neutral Sentiment: UBS reiterated its Hold rating, offering no new catalyst but indicating the firm sees limited justification for changing its current view. UBS keeps Hold rating
• Negative Sentiment: Analysts expect Allstate’s third-quarter earnings per share to decline by double digits year over year, creating concern ahead of the company’s November earnings release. What to expect from Allstate’s next quarterly earnings report
• Negative Sentiment: KBW’s continued Sell rating remains a notable overhang, suggesting the firm believes Allstate’s strong rally has outpaced its fundamental value. KBW keeps Sell rating
• Negative Sentiment: The price target for Allstate’s preferred stock was reduced 12.29% to $19.21, signaling weaker expectations for that security, although it does not directly change the valuation of the common shares. Allstate preferred stock price target decreased

Allstate Price Performance

Allstate stock opened at $253.24 on Wednesday. The business has a 50-day moving average of $245.78 and a 200-day moving average of $236.83. Allstate has a 1 year low of $188.08 and a 1 year high of $277.22. The firm has a market capitalization of $64.03 billion, a P/E ratio of 5.06, a PEG ratio of 0.56 and a beta of 0.13. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.24.

Allstate (NYSE:ALL) last released its quarterly earnings results on Wednesday, August 5th. The insurance provider reported $8.99 earnings per share for the quarter, beating the consensus estimate of $6.06 by $2.93. Allstate had a net margin of 18.97% and a return on equity of 41.64%. The company had revenue of $18.60 billion during the quarter, compared to analysts’ expectations of $15.46 billion. During the same quarter in the prior year, the company earned $5.94 earnings per share. The business’s quarterly revenue was up 11.8% compared to the same quarter last year. On average, equities analysts anticipate that Allstate will post 36.21 EPS for the current year.

About Allstate

Allstate Corp. (NYSE: ALL) is an insurance company that provides protection products and related services primarily in the United States. Its offerings include automobile, homeowners, renters, condominium, motorcycle and other personal property and casualty insurance, distributed through agents, brokers, direct channels and digital platforms.

The company also provides roadside assistance, identity-protection services and protection plans for consumer products. Through its acquisition of National General, Allstate expanded its presence in independent-agent distribution and specialty personal insurance.